Michael R. Megna Sells 9,659 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Stock

Michael R. Megna has sold 9,659 shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) stock. The transaction was reported on August 10, 2021, and the shares were sold at an average price of $34.87 per share.

Kiniksa Pharmaceuticals is a biopharmaceutical company that develops and commercializes therapies for patients with autoimmune disorders and other diseases. The company's lead product, canakinumab, is approved in the United States for the treatment of adult patients with severe asthma and adult patients with active ankylosing spondylitis.

Megna was previously the Chief Financial Officer of Kiniksa Pharmaceuticals. He resigned from his position on July 15, 2021, and has since sold his shares in the company. The reason for the sale is not disclosed.